As returns on market increase, returns on owning Pfizer are expected to decrease at a much smaller rate. During bear market, Pfizer is likely to outperform the market.
Ian Read Chairman, CEO and Chairman of Executive Committee
John Young President and General Manager - Primary Care Business Unit
Douglas Lankler Executive Vice President Chief Compliance and Risk Officer
Kristin Peck Executive Vice President - Worldwide Business Development and Innovation
Pfizer Price and Market Media
The median price of Pfizer for the period between Sat, Apr 20, 2013 and Mon, May 20, 2013 is 29.27 with a coefficient of variation of 2.7. The daily time series for the period is distributed with a sample standard deviation of 0.8, arithmetic mean of 29.52, and mean deviation of 0.66. The Stock received substential amount of media coverage during this period.
Pfizer Inc [PFE] is traded on New York Stock Exchange in USA. It is located in New York, NY and employs 91,500 people. The company currently falls under 'Mega-Cap' category with total capitalization of 205.42 B. Pfizer Inc runs under Healthcare sector within Drug Manufacturers - Major industry. This company has 7.09 B outstanding shares of which 63.42 M shares are at this time shorted by investors with about 1.8 days to cover shorted positions.
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory